Insider · CIK 0001491299
Thomas Wilder
Files at PEN (Penumbra Inc). First filing Apr 2, 2025, latest Jan 6, 2026.
In brief
Thomas Wilder files SEC Form 4 as director at PEN (Penumbra Inc). Since Apr 2, 2025, Thomas Wilder has reported 0 open-market buys worth $0 and 5 open-market sells worth $386k, the latest filed on Jan 6, 2026.
A track record needs three past buys with six months of prices behind them; Thomas Wilder has 0, so none is measured yet.
The newest scored trade: sold $58k of PEN on Jan 2, 2026, filed Jan 6, 2026, scored 30 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $58k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PEN: Penumbra Inc
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Penumbra Inc | $58k 186 shares | -100% | +37% from low-4% from high | |
| 36Weak | Penumbra Inc | $47k 186 shares | -50% | +31% from low-18% from high | |
| 39Weak | Penumbra Inc | $89k 372 shares | -50% | +33% from low-18% from high | |
| 20Weak | Penumbra Inc | $96k 360 shares | -7% | +48% from low-9% from high | |
| 20Weak | Penumbra Inc | $95k 360 shares | -7% | +43% from low-12% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 2, 2026 | PEN PENUMBRA, INC. | 186 0.00% of outstanding | $58k | Jan 2, 2026 | none |
| Oct 1, 2025 | PEN PENUMBRA, INC. | 186 0.00% of outstanding | $47k | Oct 1, 2025 | $89k |
| Aug 12, 2025 | PEN PENUMBRA, INC. | 372 0.00% of outstanding | $89k | Aug 12, 2025 | none |
| Apr 2, 2025 | PEN PENUMBRA, INC. | 360 0.00% of outstanding | $96k | Apr 2, 2025 | $95k |
| Mar 31, 2025 | PEN PENUMBRA, INC. | 360 0.00% of outstanding | $95k | Mar 31, 2025 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | PEN Penumbra Inc | AGrant or award Common Stock | +589 | $0.00 | $0 | 589 | Feb 18, 2026 |
| Jan 2, 2026 | PEN Penumbra Inc | SOpen-market sale Common Stock10b5-1 | -186 | $310.72 | $58k | 0 | Jan 6, 2026 |
| Oct 1, 2025 | PEN Penumbra Inc | SOpen-market sale Common Stock10b5-1 | -186 | $253.93 | $47k | 186 | Oct 3, 2025 |
| Aug 12, 2025 | PEN Penumbra Inc | SOpen-market sale Common Stock10b5-1 | -372 | $240.16 | $89k | 372 | Aug 13, 2025 |
| Apr 2, 2025 | PEN Penumbra Inc | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -360 | $266.93 | $96k | 4,692 | Apr 4, 2025 |
| Mar 31, 2025 | PEN Penumbra Inc | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -360 | $264.58 | $95k | 4,533 | Apr 2, 2025 |
Questions about Thomas Wilder
Answered from the filings on this page, as of the latest one.
Is Thomas Wilder buying or selling?
In the last 12 months Thomas Wilder reported 0 open-market buys worth $0 and 1 open-market sell worth $58k on SEC Form 4; the latest was sold $58k of PEN on Jan 2, 2026. Grants, option exercises and tax withholding are not counted.
How did Thomas Wilder's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas Wilder has 0.
Where does Thomas Wilder file Form 4?
Thomas Wilder has filed Form 4 at PEN (Penumbra Inc). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.